Mirabel

Contract Manufacturing at our cGMP Facility: Mirabel, Quebec

Mirabel operations is capable of non-gmp/cGMP pharmaceutical development and commercial manufacturing facility conveniently located near one of Canada’s largest pharma hubs. The facility has been manufacturing a broad portfolio of dosage forms for over 40 years with an excellent compliance record. The site has extensive regulatory reach with regulatory status with Health Canada, Health Canada, FDA, EMA, ANVISA, Korea and others.

The Mirabel facility is perfectly suited to handle either high-volume (hundreds of kilograms) or small batch (2-3 kg) manufacturing, for a wide range of solid dose, liquids – including suspensions and solutions, and nonsterile semisolids – including lotions, creams and ointments and suppositories. The facility includes laboratories for analytical method development and validation, method transfers, release and microbiology testing on both raw materials and finished goods. A variety of packaging services are also available in bottles, tubes and cartons.

Pharmaceutical Development

  • Solid dose
  • Liquids
  • Semi-solid
  • Suppository
  • Packaging
Facility Overview
Facility Size 226,000 SQFT (21,000 M²)
Regulatory Approval U.S. FDA, U.S. DEA, MHRA, ANVISA, Health Canada, EMEA
Production Capabilities
Solid Dosage 2 Billion tablets/capsule
Liquid 12 Million Liters
Suppository 100 Million Units
Ointments 325,000 Kilograms
Contact Us
Address:
17800, rue Lapointe Mirabel, Québec J7J 0W8 Canada
Phone:
450-433-7673
Email:
services@halopharma.com